Submitted by Anonymous (not verified) on 19 October 2026 - 12:02
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised